Assessing understanding of individual risk and symptoms of progressive multifocal leukoencephalopathy in patients prescribed natalizumab for multiple sclerosis
Author:
Affiliation:
1. Neurology Department; Alfred Health; Melbourne Victoria Australia
Publisher
Wiley
Subject
Internal Medicine
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/imj.13318/fullpdf
Reference24 articles.
1. Risk of natalizumab-associated progressive multifocal leukoencephalopathy;Bloomgren;N Engl J Med,2012
2. Progressive multifocal leukoencephalopathy and other forms of JC virus disease;Brew;Nat Rev Neurol,2010
3. Risk stratification for progressive multifocal leukoencephalopathy in patients treated with natalizumab;Sorensen;Mult Scler,2012
4. Stratification and monitoring of natalizumab-associated progressive multifocal leukoencephalopathy risk: recommendations from an expert group;McGuigan;J Neurol Neurosurg Psychiatry,2016
5. Biogen Australia Pty Ltd. http://tapp.com.au/
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Multiple sclerosis disease–related knowledge measurement instruments show mixed performance: a systematic review;Journal of Clinical Epidemiology;2022-09
2. Patient-based benefit-risk assessment of medicines: development, refinement, and validation of a content search strategy to retrieve relevant studies;Journal of the Medical Library Association;2021-11-28
3. Improving MS patients’ understanding of treatment risks and benefits in clinical consultations: A randomised crossover trial;Multiple Sclerosis and Related Disorders;2021-04
4. Rituximab utilization for approved and off‐label nononcology indications and patients’ experiences with the Patient Alert Card;Pharmacology Research & Perspectives;2020-01-03
5. Towards a More User-Friendly Medication Information Delivery to People Living with Multiple Sclerosis: A Case Study with Alemtuzumab;Advances in Experimental Medicine and Biology;2019
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3